Addition of clinical research and strategic partnership teams marks another milestone for Qbtech in North America, bolstering the company’s regional capabilities and footprint HOUSTON, June 02, 2025-- ...

LONDON & HOUSTON--(BUSINESS WIRE)--The Focus ADHD program, created by objective testing provider Qbtech and the AHSN Network, received the Best Innovative Mental Health Invention at the 2022 National ...

HOUSTON--(BUSINESS WIRE)--As the Public Health Emergency (PHE) expires, it’s evident how far we have come in providing care and treatment, yet there is still substantial work to be done. Qbtech, Inc., ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Thanks to growth from an equity ...

Texas office will serve as home base for U.S. operations, expanding the company's presence in the market and contributing to the local economy Qbtech, the global leader in objective ADHD testing, ...

Data presented at ADHD World Congress highlights how QbCheck supports diagnostic accuracy and individualized treatment monitoring, enabling efficient and robust care in virtual settings. News Summary: ...

Qbtech’s computer-based diagnostic tool QbTest has been recommended by the UK’s National Institute for Clinical Excellence (NICE) to support the diagnosis of attention deficit hyperactivity disorder ...

STOCKHOLM & HOUSTON–(BUSINESS WIRE)–Today, Qbtech announces a partnership in The Netherlands with one of the leading ADHD care providers, ADHDcentraal. The purpose of the collaboration is to create ...

The US Food and Drug Administration (FDA) has cleared the ADHD test-QbCheck-developed by the Swedish company Qbtech to aid in the assessment and evaluation of treatment interventions in patients with ...

Today, Qbtech, the software provider of objective ADHD tests QbTest and QbCheck, announces an investment by specialist growth equity investor, Verdane. Qbtech is the market leader in objective ...